Tranzactioneaza Avadel Pharmaceuticals Plc Spon Adr Each Rep 1 Ord Shs (US.AVDL) - 14.51 USD (%) Tranzactioneaza
Indici
Descriere companie
Avadel Pharmaceuticals plc (www.avadel.com) is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or controlled release solid, oral dosage formulations of drugs. Its LiquiTime technology allows for development of modified/controlled release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of extended-/modified-release injectable dosage formulations of drugs.